Skip to Main Content

Author Details

Stephen A Migueles
National Institute of Allergy and Infectious Diseases, National Institutes of Health
1998
82
44
Nevan J Krogan (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37450602An open label randomized controlled trial of atorvastatin versus aspirin in elite controllers and antiretroviral-treated people with HIV.AIDS2023
38096385HIV vaccines induce CD8<sup>+</sup> T cells with low antigen receptor sensitivity.Science2023
35041523Differential Expression of CREM/ICER Isoforms Is Associated with the Spontaneous Control of HIV Infection.mBio2022
33471124Lost in Translation: Lack of CD4 Expression due to a Novel Genetic Defect.J Infect Dis2021
33536176Evaluating a New Class of AKT/mTOR Activators for HIV Latency Reversing Activity <i>Ex Vivo and In Vivo</i>.J Virol2021
33529172A replication-competent adenovirus-vectored influenza vaccine induces durable systemic and mucosal immunity.J Clin Invest2021
34506540The impact of the 2014 Ebola epidemic on HIV disease burden and outcomes in Liberia West Africa.PLoS One2021
34228640Naive infection predicts reservoir diversity and is a formidable hurdle to HIV eradication.JCI Insight2021
32907983Antigenic Restimulation of Virus-Specific Memory CD8<sup>+</sup> T Cells Requires Days of Lytic Protein Accumulation for Maximal Cytotoxic Capacity.J Virol2020
30760706Longitudinal HIV sequencing reveals reservoir expression leading to decay which is obscured by clonal expansion.Nat Commun2019
31830058Toll-like receptor 7-adapter complex modulates interferon-α production in HIV-stimulated plasmacytoid dendritic cells.PLoS One2019
31415245Adoptive lymphocyte transfer to an HIV-infected progressor from an elite controller.JCI Insight2019
31241541ART in HIV-Positive Persons With Low Pretreatment Viremia: Results From the START Trial.J Acquir Immune Defic Syndr2019
31004012Prolonged evolution of the memory B cell response induced by a replicating adenovirus-influenza H5 vaccine.Sci Immunol2019
29461980Killer cell immunoglobulin-like receptor 3DL1 variation modifies HLA-B*57 protection against HIV-1.J Clin Invest2018
29875402MAdCAM costimulation through Integrin-α4β7 promotes HIV replication.Mucosal Immunol2018
27453467Multiple Origins of Virus Persistence during Natural Control of HIV Infection.Cell2016
26663780IL-12-Dependent Cytomegalovirus-Specific CD4+ T Cell Proliferation, T-bet Induction, and Effector Multifunction during Primary Infection Are Key Determinants for Early Immune Control.J Immunol2016
27851912Identification of a CD4-Binding-Site Antibody to HIV that Evolved Near-Pan Neutralization Breadth.Immunity2016
27760334Class II-Restricted CD8s: New Lessons Violate Old Paradigms.Immunity2016
27630237Monitoring Integration over Time Supports a Role for Cytotoxic T Lymphocytes and Ongoing Replication as Determinants of Reservoir Size.J Virol2016
25600384Should all research subjects be treated the same?Hastings Cent Rep2015
26546609Reversible Reprogramming of Circulating Memory T Follicular Helper Cell Function during Chronic HIV Infection.J Immunol2015
26537682A Subset of CD4/CD8 Double-Negative T Cells Expresses HIV Proteins in Patients on Antiretroviral Therapy.J Virol2015
26702094Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection.Sci Transl Med2015
25988888Success and failure of the cellular immune response against HIV-1.Nat Immunol2015
25711322Clinical and demographic factors associated with low viral load in early untreated HIV infection in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial.HIV Med2015
24227851Increased sequence coverage through combined targeting of variant and conserved epitopes correlates with control of HIV replication.J Virol2014
26137533CD8(+) T-cell Cytotoxic Capacity Associated with Human Immunodeficiency Virus-1 Control Can Be Mediated through Various Epitopes and Human Leukocyte Antigen Types.EBioMedicine2014
26023356HIV-1 Treated Patients with Undetectable Viral Loads have Lower Levels of Innate Immune Responses via Cytosolic DNA Sensing Systems Compared with Healthy Uninfected Controls.J AIDS Clin Res2014
25186731Broad and potent HIV-1 neutralization by a human antibody that binds the gp41-gp120 interface.Nature2014
24554663CD4+ memory stem cells are infected by HIV-1 in a manner regulated in part by SAMHD1 expression.J Virol2014
24185941Evidence for innate immune system activation in HIV type 1-infected elite controllers.J Infect Dis2014
23468632Cytotoxic capacity of SIV-specific CD8(+) T cells against primary autologous targets correlates with immune control in SIV-infected rhesus macaques.PLoS Pathog2013
23951263Gag-positive reservoir cells are susceptible to HIV-specific cytotoxic T lymphocyte mediated clearance in vitro and can be detected in vivo [corrected].PLoS One2013
24030440Isolation of human monoclonal antibodies from peripheral blood B cells.Nat Protoc2013
23661761Delineating antibody recognition in polyclonal sera from patterns of HIV-1 isolate neutralization.Science2013
22278241HLA B*5701-positive long-term nonprogressors/elite controllers are not distinguished from progressors by the clonal composition of HIV-specific CD8+ T cells.J Virol2012
23014521Concurrent measures of total and integrated HIV DNA monitor reservoirs and ongoing replication in eradication trials.AIDS2012
23151583Broad and potent neutralization of HIV-1 by a gp41-specific human antibody.Nature2012
22445844Inhibitory Killer Immunoglobulin-like Receptors to self HLA-B and HLA-C ligands contribute differentially to Natural Killer cell functional potential in HIV infected slow progressors.Clin Immunol2012
22444629Small molecules and big killers: the challenge of eliminating the latent HIV reservoir.Immunity2012
22490332Comprehensive analysis of unique cases with extraordinary control over HIV replication.Blood2012
22674985Antibody-dependent cellular cytotoxicity against primary HIV-infected CD4+ T cells is directly associated with the magnitude of surface IgG binding.J Virol2012
21399496Qualitative features of the HIV-specific CD8+ T-cell response associated with immunologic control.Curr Opin HIV AIDS2011
21841160Partial immune reconstitution of X-linked hyper IgM syndrome with recombinant CD40 ligand.Blood2011
21921725HIV/HCV-coinfected natural viral suppressors have better virologic responses to PEG-IFN and ribavirin than ARV-treated HIV/HCV patients.J Acquir Immune Defic Syndr2011
21383976Trivalent adenovirus type 5 HIV recombinant vaccine primes for modest cytotoxic capacity that is greatest in humans with protective HLA class I alleles.PLoS Pathog2011
21383972Elite suppressors harbor low levels of integrated HIV DNA and high levels of 2-LTR circular HIV DNA compared to HIV+ patients on and off HAART.PLoS Pathog2011
21471235Receptor-ligand requirements for increased NK cell polyfunctional potential in slow progressors infected with HIV-1 coexpressing KIR3DL1*h/*y and HLA-B*57.J Virol2011
  • 1 - 50 of 82

Recommended Authors

Deepashri Rao
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 2018
Number of shared co-authors 10
Xiaoyu Luo
Gladstone Institutes, University of California san francisco
Career Start Year 2014
Number of shared co-authors 14
Amy L Ellis-Connell
University of Wisconsin
Career Start Year 2010
Number of shared co-authors 0
Chi N Chan
Vaccine & Gene Therapy Institute, Oregon Health & Science University
Career Start Year 2010
Number of shared co-authors 4
Suzannah J Rihn
MRC-University of Glasgow Centre for Virus Research, University of Glasgow
Career Start Year 2008
Number of shared co-authors 5
Vanessa A York
University of California San Francisco
Career Start Year 2008
Number of shared co-authors 6
Glenda Canderan
University of Virginia
Career Start Year 2003
Number of shared co-authors 1
Jennifer M Lund
Fred Hutchinson Cancer Research Center
Career Start Year 2003
Number of shared co-authors 1
Sheila M Keating
University of California San Francisco
Career Start Year 2002
Number of shared co-authors 5
Philip J Norris
Vitalant Research Institute
Career Start Year 2001
Number of shared co-authors 11
Alberto Bosque
George Washington University
Career Start Year 2000
Number of shared co-authors 4
Edward P Browne
University of North Carolina at Chapel Hill
Career Start Year 2000
Number of shared co-authors 0
Maudi Killian
University of California San Francisco
Career Start Year 1999
Number of shared co-authors 5
Viviana Simon
Icahn School of Medicine at Mount Sinai
Career Start Year 1997
Number of shared co-authors 3
Cynthia A Derdeyn
University of Washington
Career Start Year 1995
Number of shared co-authors 6
Ulf Dittmer
University Hospital Essen, University of Duisburg-Essen, Institute for Virology
Career Start Year 1993
Number of shared co-authors 10
Sharon R Lewin
The University of Melbourne at the Peter Doherty Institute for Infection and Immunity
Career Start Year 1993
Number of shared co-authors 16
Alicja Trocha
Ragon Institute of MGH
Career Start Year 1991
Number of shared co-authors 12
Vicente Planelles
University of Utah
Career Start Year 1991
Number of shared co-authors 6
Ann L Erickson
California Pacific Medical Center Research Institute
Career Start Year 1991
Number of shared co-authors 2
Olivier Schwartz
Institut Pasteur, Universite Paris Cite, CNRS UMR9
Career Start Year 1987
Number of shared co-authors 8
Ian Frank
IF School of Medicine, University of Pennsylvania
Career Start Year 1987
Number of shared co-authors 11
Michael C Keefer
MK University of Rochester
Career Start Year 1986
Number of shared co-authors 3
Kim J Hasenkrug
National Institute of Allergy and Infectious Diseases
Career Start Year 1986
Number of shared co-authors 12
Mohan Somasundaran
University of Massachusetts Chan Medical School
Career Start Year 1985
Number of shared co-authors 2
Robert F Siliciano
Johns Hopkins University School of Medicine
Career Start Year 1978
Number of shared co-authors 20
Joseph B Margolick
Johns Hopkins Bloomberg School of Public Health
Career Start Year 1973
Number of shared co-authors 10
Ruth M Ruprecht
University of Texas San Antonio
Career Start Year 1971
Number of shared co-authors 2
Douglas D Richman
Center for AIDS Research, University of California San Diego
Career Start Year 1970
Number of shared co-authors 17
Jay A Berzofsky
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1966
Number of shared co-authors 9

Collaborators

Mark Connors
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Co-authored papers 63
Nicole A Doria-Rose
Co-authored papers 11
John R Mascola
Co-authored papers 11
Richard T Davey
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Co-authored papers 5
Peter D Kwong
Co-authored papers 5
Sijy O'Dell
Co-authored papers 5
Mark K Louder
Co-authored papers 5
Steven G Deeks
University of California san francisco
Co-authored papers 5
Jeffrey D Lifson
Frederick National Laboratory
Co-authored papers 4
Jason M Brenchley
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Co-authored papers 4
Lawrence Shapiro
Zuckerman Mind Brain Behaviour Institute
Co-authored papers 3
Barton F Haynes
Co-authored papers 3
Margaret Juliana McElrath
Co-authored papers 3
Adrian B McDermott
Co-authored papers 3
Gwo-Yu Chuang
Co-authored papers 3
Henry Clifford Lane
Division of Clinical Research, National Institutes of Allergy and Infectious Diseases
Co-authored papers 3
Baoshan Zhang
Co-authored papers 3
Tongqing Zhou
Co-authored papers 3
Ivelin S Georgiev
Co-authored papers 3
Steven A Rosenberg
University of Colorado School of Medicine
Co-authored papers 2
Jessica N Hodge
Johns Hopkins University
Co-authored papers 2
Bertha Hidalgo
Co-authored papers 2
Jonathan M Carlson
Co-authored papers 2
Aliaksandr Druz
Co-authored papers 2
George M Shaw
Co-authored papers 2
Michael G Joyce
Co-authored papers 2
Stefania Pittaluga
National Cancer Institute, National Institutes of Health
Co-authored papers 2
Cécile Tremblay
Co-authored papers 2
Nicole F Bernard
Co-authored papers 2
Yongping Yang
Co-authored papers 2
Release 1.2